+

WO1999046375A3 - Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques - Google Patents

Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques Download PDF

Info

Publication number
WO1999046375A3
WO1999046375A3 PCT/DE1999/000722 DE9900722W WO9946375A3 WO 1999046375 A3 WO1999046375 A3 WO 1999046375A3 DE 9900722 W DE9900722 W DE 9900722W WO 9946375 A3 WO9946375 A3 WO 9946375A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid sequences
prostate tissue
human nucleic
sequences
Prior art date
Application number
PCT/DE1999/000722
Other languages
German (de)
English (en)
Other versions
WO1999046375A2 (fr
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Original Assignee
Metagen Gesellschaft Fuer Genomforschung Mbh
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagen Gesellschaft Fuer Genomforschung Mbh, Thomas Specht, Bernd Hinzmann, Armin Schmitt, Christian Pilarsky, Edgar Dahl, Andre Rosenthal filed Critical Metagen Gesellschaft Fuer Genomforschung Mbh
Priority to EP99920546A priority Critical patent/EP1068318A2/fr
Priority to JP2000535742A priority patent/JP2002505878A/ja
Publication of WO1999046375A2 publication Critical patent/WO1999046375A2/fr
Publication of WO1999046375A3 publication Critical patent/WO1999046375A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des séquences d'acide nucléique humaines, ARNm, ADNc, séquences génomiques, issues de tissus prostatiques normaux, qui codent les produits géniques ou des parties de produits géniques, ainsi que l'utilisation desdites séquences. L'invention concerne en outre les polypeptides pouvant être obtenus par l'intermédiaire desdites séquences et leur utilisation.
PCT/DE1999/000722 1998-03-10 1999-03-09 Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques WO1999046375A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99920546A EP1068318A2 (fr) 1998-03-10 1999-03-09 Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
JP2000535742A JP2002505878A (ja) 1998-03-10 1999-03-09 前立腺組織由来のヒト核酸配列

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19811194A DE19811194A1 (de) 1998-03-10 1998-03-10 Menschliche Nukleinsäuresequenzen aus Prostatagewebe
DE19811194.0 1998-03-10

Publications (2)

Publication Number Publication Date
WO1999046375A2 WO1999046375A2 (fr) 1999-09-16
WO1999046375A3 true WO1999046375A3 (fr) 2000-07-06

Family

ID=7860959

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/000722 WO1999046375A2 (fr) 1998-03-10 1999-03-09 Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques

Country Status (4)

Country Link
EP (1) EP1068318A2 (fr)
JP (1) JP2002505878A (fr)
DE (1) DE19811194A1 (fr)
WO (1) WO1999046375A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073454A1 (fr) * 1999-06-02 2000-12-07 Genentech, Inc. Polypeptides transmembranaires secretes et acides nucleiques codants pour ceux-ci
US20030068623A1 (en) 1997-06-16 2003-04-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
SK12242001A3 (sk) * 1999-03-04 2002-06-04 Merck Patent Gmbh Histidínproteínfosfatáza
AU2001247460A1 (en) * 2000-03-15 2001-09-24 Millennium Pharmaceuticals, Inc. 18615 and 48003, human ion channels and uses therefor
CA2427518A1 (fr) * 2000-10-30 2002-05-10 Bristol-Myers Squibb Company Polynucleotide codant pour une proteine derivee d'un lymphocyte t humain active liee a une enzyme se conjuguant a l'ubiquitine
WO2004090098A2 (fr) * 2003-04-01 2004-10-21 The Regents Of The University Of California Regulation de la transcription d'acide nucleique impliquant la phosphatase

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036535A2 (fr) * 1996-03-29 1997-10-09 Board Of Regents, The University Of Texas System Biomarqueurs servant a effectuer la detection, le diagnostic et le pronostic du cancer de la prostate
WO1998004689A1 (fr) * 1995-07-31 1998-02-05 Urocor, Inc. Biomarqueurs et cibles de diagnostic, de pronostic et de traitement du cancer de la prostate
WO1999006548A2 (fr) * 1997-08-01 1999-02-11 Genset Est 5' pour proteines secretees sans specificite tissulaire

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004689A1 (fr) * 1995-07-31 1998-02-05 Urocor, Inc. Biomarqueurs et cibles de diagnostic, de pronostic et de traitement du cancer de la prostate
WO1997036535A2 (fr) * 1996-03-29 1997-10-09 Board Of Regents, The University Of Texas System Biomarqueurs servant a effectuer la detection, le diagnostic et le pronostic du cancer de la prostate
WO1999006548A2 (fr) * 1997-08-01 1999-02-11 Genset Est 5' pour proteines secretees sans specificite tissulaire

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"nj50f01.s1 NCI_CGAP_Pr9 Homo sapiens cDNA clone IMAGE:995929", EMBL DATABASE ENTRY HS1321049; ACCESSION NUMBER AA531076 (VERSION 2), 19 August 1997 (1997-08-19), XP002127855 *
"ns58d08.s1 NCI_CGAP_Pr22 Homom sapiens cDNA clone IMAGE:1187823", EMBL DATABASE ENTRY AA662096 (VERSION 2), 5 December 1997 (1997-12-05), XP002127857 *
BONFIELD, J. ET AL.: "A new sequence assembly program", NUCLEIC ACIDS RESEARCH., vol. 23, 1995, pages 4992-9, XP002127627, ISSN: 0305-1048 *
DONG, J.-T. ET AL.: "KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2", SCIENCE., vol. 268, 12 May 1995 (1995-05-12), pages 884 - 886, XP002127854 *
HILLIER, L. ET AL.: "WashU-Merck EST project 1997: zw53c09.r1 Soares total fetus Nb2HF8 9w Homo sapiens cDNA clone 773776 5'", EMBL DATABASE ENTRY HS1236638; ACCESSION NUMBER AA434549, 1 June 1997 (1997-06-01), XP002127856 *
HILLIER, L. ET AL.: "WashU-Merck EST project: yw79g09.s1 Homo sapiens cDNA clone 258496 3'", EMBL DATABASE ENTRY HS908263; ACCESSION NUMBER N25908, 30 December 1995 (1995-12-30), XP002127858 *
SCHULER, G. D.: "Sequence mapping by electronic PCR", GENOME RESEARCH., vol. 7, 1997, pages 541 - 550, XP002127628, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
DE19811194A1 (de) 1999-09-16
EP1068318A2 (fr) 2001-01-17
WO1999046375A2 (fr) 1999-09-16
JP2002505878A (ja) 2002-02-26

Similar Documents

Publication Publication Date Title
WO1999047669A3 (fr) Sequences d'acide nucleique humain tirees de tissus de tumeurs du sein
WO1999055858A3 (fr) Sequences nucleotidiques humaines obtenues a partir d'un tissu tumoral du pancreas
WO1999053040A3 (fr) Sequences d'acide nucleique humain provenant de tissu de tumeur ovarienne
WO1999054461A3 (fr) Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre
EP1308459A3 (fr) Séquences d'ADN complementaires pleine longueur
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
EP1440981A3 (fr) ADN complementaire humaine de pleine longueur
WO1999038972A9 (fr) Genes humains et produits ii d'expression genique
WO2002002624A3 (fr) Molecules de type b7 et utilisation de ces molecules
WO1999051727A3 (fr) Sequences d'acides nucleiques humaines extraites des tissus sains d'ovaires
WO2001070977A3 (fr) Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
WO1999046374A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
WO2001068854A3 (fr) Molecules s'apparentant au facteur de croissance des fibroblastes et leurs utilisations
WO1998059040A3 (fr) Sous-unite de telomerase catalytique humaine et son utilisation therapeutique et diagnostique
WO1999054460A3 (fr) Sequences d'acide nucleique provenant du tissu normal de la vessie
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d'un seul nucleotide et utilisations de ces acides nucleiques
WO1999054353A3 (fr) Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
WO1999046375A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
WO2001042474A3 (fr) Molecules de type interferon et utilisations
WO2004076614A3 (fr) Sequences d'acide nucleique humaines issues de carcinomes de la prostate
WO1999047655A3 (fr) Sequences d'acides nucleiques humains provenant de tissus mammaires sains
WO2001040521A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
WO2001048245A3 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants
WO2005011725A3 (fr) Agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999920546

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09623746

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999920546

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1999920546

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999920546

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载